Investment
Features
FeesSafety
Academy
More
Pluang+

BOJ hikes rates to 1.25%, highest since 1995, but yen weakens and stocks rise unexpectedly

Market News
18 Sep 2026
CNBC
View Source
Neutral
BOJ hikes rates to 1.25%, highest since 1995, but yen weakens and stocks rise unexpectedly

The Bank of Japan raised its policy rate by 25 basis points to 1.25%, the highest level since 1995, just three months after its previous hike. Despite this, the yen weakened against the dollar, 10-year government bond yields fell, and the Nikkei 225 stock index rose 1.5%, an unusual market reaction attributed to two dissenting votes on the rate decision and the lack of updated economic forecasts. Experts suggest another rate hike could come in December, but opinions vary on how high rates will ultimately go, with some expecting a peak between 1.75% and 2% in 2027. The BOJ remains cautious, balancing inflation targets with concerns over economic growth amid global uncertainties.

Japan's central bank rate hike is the story's subject, providing context for financial markets. For readers following Financials, here is Pluang's market snapshot as of Sep 18, 2026 14:41 WIB: 51 of 74 Financials-sector US stocks rose, 16 fell. Notable movers include Nomura Holdings Inc at USD 10.09 with a 1-day change of -1.37% and 89% sell order activity, KKR & Co Inc at USD 98.10 up 1.30% with 100% buy order activity, and Prudential PLC at USD 26.58 up 1.22% with 100% buy order activity.

More News

Gulfport Energy VP sells 325 shares for $59,400

Gulfport Energy VP sells 325 shares for $59,400

Gulfport Energy's Vice President, Willrath, sold 325 shares of the company's stock, generating $59,400 from the transaction. This insider sale may indicate personal financial decisions or portfolio adjustments but does not necessarily reflect the com...

Market News
Neutral
2 hours ago
Vor Biopharma advances global trials for telitacicept with strong funding and data, eyeing 2027 results.

Vor Biopharma advances global trials for telitacicept with strong funding and data, eyeing 2027 results.

Vor Biopharma is progressing its global Phase 3 trials for telitacicept in treating myasthenia gravis and Sjögren’s syndrome, with full enrollment achieved and topline data expected in the first half of 2027. The company benefits from strong clinical...

Market News
Neutral
4 hours ago
$1M hybrid portfolio can yield $6,000 monthly income with growth and capital protection.

$1M hybrid portfolio can yield $6,000 monthly income with growth and capital protection.

A $1 million hybrid investment portfolio can generate a sustainable monthly income of $6,000 by balancing dividend growth stocks, credit assets, real assets, options, and commodities. This diversified approach aims to provide steady income while prot...

Others
Bullish
4 hours ago
Ethereum's Glamsterdam upgrade launches on Sepolia testnet Oct 6 amid security concerns.

Ethereum's Glamsterdam upgrade launches on Sepolia testnet Oct 6 amid security concerns.

Ethereum plans to activate its major Glamsterdam upgrade on the Sepolia testnet on October 6, 2026, introducing Enshrined Proposer-Builder Separation (ePBS) to increase block capacity and transaction processing time. However, developers have raised s...

Protocol Fundamentals
Neutral
4 hours ago
NEAR Protocol jumps 45% in 3 days on new confidential trading and rewards program

NEAR Protocol jumps 45% in 3 days on new confidential trading and rewards program

NEAR Protocol's token surged 45% from $2.34 to $3.45 within three days, driven by the launch of confidential perpetual trading via Hyperliquid and a new rewards initiative called Push to $3.33. The platform now supports private leveraged trading acro...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App